• Prestained Protein Marker (Triple color, EDTA free, 10-250 k

  2026-06-29

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides a visible, EDTA-free molecular weight standard for accurate protein sizing and transfer verification in SDS-PAGE and Western blot workflows. It is not designed for quantification or for use outside electrophoresis and blotting applications.

• Dabigatran Etexilate: Innovations in Oral Anticoagulation fo

  2026-06-29

  Dabigatran etexilate represents a significant advancement as the first oral direct thrombin inhibitor approved for reducing stroke and systemic embolism risk in nonvalvular atrial fibrillation and for venous thromboembolism prevention. The reference study highlights its predictable pharmacokinetics, efficacy, and practical advantages over traditional anticoagulants, with important implications for clinical and translational cardiovascular research.

• Pexmetinib (ARRY-614): Optimized Assays for p38 MAPK & Tie2

  2026-06-28

  Pexmetinib (ARRY-614) empowers researchers with dual-action kinase inhibition for advanced cytokine suppression and pathway dissection. This guide translates recent mechanistic breakthroughs into actionable protocols, troubleshooting steps, and comparative insights for reliable results with APExBIO’s trusted reagent.

• BODIPY 581/591 C11: Ratiometric Fluorescent Probe for Lipid

  2026-06-27

  BODIPY 581/591 C11 excels as a ratiometric fluorescent probe, precisely quantifying lipid peroxidation and oxidative stress in live cells. Its robust photostability and unique emission shift enable reproducible, high-sensitivity antioxidant capacity evaluation, elevating ferroptosis and redox biology workflows.

• KPT330 Enhances CRISPR-Cas9 Editing Precision via mRNA Expor

  2026-06-26

  The referenced study uncovers a novel approach to improving CRISPR-Cas9 genome and base editing precision by using KPT330, a selective nuclear export inhibitor. By modulating the nuclear export of Cas9 mRNA, KPT330 indirectly restricts Cas9 activity, leading to enhanced specificity and reduced off-target effects in mammalian cells.

• Digoxin as a Na+/K+ ATPase Pump Inhibitor: Applied Workflows

  2026-06-26

  Digoxin uniquely bridges cardiac and antiviral research through robust Na+/K+ ATPase inhibition, enabling precise modulation of contractility and viral susceptibility in cell-based and animal models. This article delivers actionable protocols, real-world troubleshooting, and insights for maximizing Digoxin’s impact—backed by APExBIO’s high-purity formulation.

• THZ1: Covalent CDK7 Inhibitor Workflows for T-ALL Research

  2026-06-25

  THZ1, an irreversible covalent CDK7 inhibitor, empowers cancer researchers to dissect transcriptional dependencies and overcome resistance mechanisms, especially in T-ALL. This guide delivers evidence-driven protocols, troubleshooting strategies, and workflow enhancements for maximizing THZ1's selectivity and efficacy in advanced cancer biology studies.

• Nanobody Targeting PstS-1 in M. tuberculosis Granuloma: Diag

  2026-06-25

  Dhekale et al. (2025) isolated a camelid nanobody targeting the Mycobacterium tuberculosis PstS-1 antigen and demonstrated its robust immunoreactivity within granulomatous structures. This innovation supports future molecular imaging approaches for improved TB diagnosis, especially in challenging paucibacillary or extrapulmonary cases.

• Reliable Hepatocyte Maturation: FH1 (Catalog No. B3700) in P

  2026-06-24

  This article addresses real laboratory challenges in iPS cell-to-hepatocyte workflows, focusing on how FH1 (Catalog No. B3700) (SKU B3700) enables reproducible, high-functionality iHeps. Scenario-based Q&As provide actionable advice, vendor selection guidance, and protocol insights, supporting evidence-based adoption of FH1 for advanced liver research.

• VE-821 ATR Kinase Inhibitor: Precision in DDR Research

  2026-06-23

  VE-821 delivers highly selective ATR kinase inhibition, redefining DNA damage response assays and radiosensitization workflows. Learn how to optimize protocols, troubleshoot common pitfalls, and leverage cross-domain insights for advanced DNA repair pathway research.

• Talin1–Piezo1–YAP Axis Regulates Endothelial Inflammation in

  2026-06-23

  A new study demonstrates that Talin1 upregulation in endothelial cells drives inflammation and atherosclerotic plaque development by modulating the Piezo1–YAP signaling axis. These mechanistic insights highlight Talin1 as a potential anti-inflammatory target and underscore the role of calcium influx in vascular pathology.

• EGTA Applications: Precision Calcium Chelation in Neuroprote

  2026-06-22

  EGTA (egtaizic acid) enables precise modulation of calcium-dependent pathways, unlocking advanced workflows in neuroprotection and apoptosis studies. This article bridges bench research and experimental troubleshooting, with actionable protocol guidance and insights drawn from recent breakthroughs in cardiac vagal neuron models.

• Calpeptin: Calpain Inhibitor Workflows in Pulmonary Fibrosis

  2026-06-22

  Calpeptin delivers nanomolar potency and exceptional selectivity for calpain, enabling precise modulation of fibrosis and inflammation pathways in advanced disease models. This guide details protocol enhancements, troubleshooting, and new translational opportunities for researchers leveraging Calpeptin from APExBIO.

• HyperTrap Heparin HP Column: Precision Tools for Stemness an

  2026-06-21

  Explore how the HyperTrap Heparin HP Column leverages HyperChrom Heparin HP Agarose for advanced purification of signaling molecules vital to cancer stemness research. Uncover unique insights into optimizing workflows for CCR7–Notch1 axis investigations.

• Morning Endurance Training Boosts Adaptation in Mice

  2026-06-20

  Hesketh et al. demonstrate that endurance training in the early active phase (morning) elicits greater performance improvements and muscle adaptations in mice than identical training performed in the afternoon. These results clarify the influence of exercise timing on adaptation, informing experimental design in circadian and metabolic research.

16322 records 1/1089 page Next 12345 下5页 Last page